Reference
Cheng W, et al. A novel intergenic region ALK fusion is targetable by alectinib in a non-small cell lung cancer patient with brain metastasis. Anti-Cancer Drugs 33: 1182-1185, No. 10, Nov 2022. Available from: URL: http://doi.org/10.1097/CAD.0000000000001363
Rights and permissions
About this article
Cite this article
Carboplatin/pemetrexed. Reactions Weekly 1932, 168 (2022). https://doi.org/10.1007/s40278-022-27533-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-27533-1